Home › Post-COVID Conditions (Long COVID) › Michigan
Post-COVID Conditions (Long COVID) clinical trials in Michigan
6 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Michigan.
Cities in Michigan
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Henry Ford St John TM Center for Infectious Disease Research ( Site 3766), Grosse Pointe Woods
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Detroit
- Research Site, Royal Oak
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- University of Michigan, Ann Arbor
- Henry Ford Hospital, Detroit
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Revival Research Institute, LLC, Dearborn
- Henry Ford St. John Hospital, Grosse Pointe Woods
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT06679140Predictors of Post-COVID-19 Clinical and Cognitive Consequences
- John D. Dingell VA Medical Center, Detroit, MI, Detroit
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT06291870Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- University of Michigan, Ann Arbor
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 12, 2024 · NCT02735707From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.